2023
Utilization of PROMIS Neuropathic Pain Quality for Detection and Monitoring Neuropathic Pain in Heel Pain Patients
Joo P, Lee W, Hoffman S, Baumhauer J, Oh I. Utilization of PROMIS Neuropathic Pain Quality for Detection and Monitoring Neuropathic Pain in Heel Pain Patients. Foot & Ankle Orthopaedics 2023, 8: 24730114231213620. PMID: 38058978, PMCID: PMC10697051, DOI: 10.1177/24730114231213620.Peer-Reviewed Original ResearchBody mass indexNeuropathic painPhysical functionNeuropathic pain qualitiesPain interferencePain patientsPain qualityBack/neck painPrevalence of NPWorse pain interferenceOnly independent factorProspective cohort studyTime pointsLow physical functionAnxiety/depressionNeck painHeel painCohort studyAnkle patientsMass indexMean ageInitial screening toolLinear mixed modelingIndependent factorsSelf-efficacy scoresAnti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause
Santoro N, Flyckt R, Davis A, Finkelstein J, Crawford S, Sun F, Derby C, Morrison A, Sluss P, Zhang H. Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause. Obstetrics And Gynecology 2023, 141: 331-340. PMID: 36649324, PMCID: PMC9858351, DOI: 10.1097/aog.0000000000005049.Peer-Reviewed Original ResearchConceptsFinal menstrual periodAnti-Müllerian hormone levelsAMH levelsNatural menopauseHormone levelsUndetectable AMH levelsCommunity-based studyOvarian conservationOvarian reserveAMH measurementOvarian failureMenstrual periodSurgery dateHysterectomyLinear mixed modelingMenopauseSurvival analysisPatientsImmediate reductionMixed modelingWomenOvariesSimilar patternRapid declineBSO
2019
Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice.
Stover A, Urick B, Deal A, Jansen J, Henson S, Miller R, Smith T, Scholle S, Chiang A, Cleeland C, Deutsch Y, Zylla D, Pitzen C, Snyder C, McNiff K, Krzyzanowska M, Spears P, Smith M, Geoghegan C, Basch E. Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice. Journal Of Clinical Oncology 2019, 37: 173-173. DOI: 10.1200/jco.2019.37.27_suppl.173.Peer-Reviewed Original ResearchOncology practiceSymptom managementOutcome performance measuresCancer typesCommunity oncology practicesRisk-adjustment variablesNational Quality ForumRisk-adjusted ratesActionable symptomsChemotherapy cyclesSymptom burdenInsurance typeInclusion criteriaLinear mixed modelingPractice variationGeneralized linear mixed modelingDay 5SymptomsQuality ForumPatientsRA variablesPractice levelMeaningful thresholdMulti-stakeholder consensusMixed modeling
2016
Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure
Hanberg JS, Sury K, Wilson FP, Brisco MA, Ahmad T, Maaten J, Broughton JS, Assefa M, Tang WH, Parikh CR, Testani JM. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. Journal Of The American College Of Cardiology 2016, 67: 2199-2208. PMID: 27173030, PMCID: PMC4867078, DOI: 10.1016/j.jacc.2016.02.058.Peer-Reviewed Original ResearchConceptsPulmonary artery catheterizationBlood urea nitrogenCardiac indexRenal functionHeart failureRenal dysfunctionGood renal functionReduced cardiac indexHigher cardiac indexGlomerular filtration rateSignificant inverse correlationMultiple subgroupsMulticenter populationWorse eGFRHF patientsCreatinine ratioArtery catheterizationPatient subgroupsFiltration rateSerial assessmentLinear mixed modelingESCAPE trialPatientsUrea nitrogenDysfunction
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply